Thematic photoMartin FalbisonerCC BY-SA 3.0Resized, encoded as WebP; displayed with responsive cropping under the original licenceSEC EDGAR published this disclosure on 2026-08-10. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001100682-26-000124
acquired disposedD
codeM
direct or indirectD
form4
is derivativetrue
issuer nameCHARLES RIVER LABORATORIES INTERNATIONAL, INC.
labelExercise of derivative
Source record & verificationDates, provenance and technical details
Context
links are based on the recorded entity typeRecorded payloadStructured source data
Recorded payload
JSON payload as stored after parsing{
"accession": "0001100682-26-000124",
"acquired_disposed": "D",
"code": "M",
"direct_or_indirect": "D",
"form": "4",
"is_derivative": true,
"issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
"label": "Exercise of derivative",
"person_name": "Knell Michael Gunnar",
"price": 0,
"role": "SVP, Finance and CAO",
"security": "Stock Options (Right to Buy)",
"shares": 1205,
"shares_owned_after": 402,
"source_path": "edgar/data/1100682/0001100682-26-000124.txt",
"ticker": "CRL",
"transaction_date": "2026-08-06",
"value": null
}Evidence-based analysis
facts, provenance and explicit model coverageDescriptive evidence from the stored source record; it is not advice, a forecast or a legal conclusion.